title: Optimized sample preparation for MALDI mass spectrometry analysis of protected synthetic peptides.
abstract: The recent development and commercialization of Fuzeon (enfuvirtide) demonstrated that a convergent strategy comprised of both solid- and solution-phase synthetic methodologies presents a viable route for peptide manufacturing on a multi-ton scale. In this strategy, the target sequence is prepared by stepwise solid-phase synthesis of protected peptide fragments, which are then coupled together in the solution-phase to give the full-length sequence. These synthetic methodologies pose a unique challenge for mass spectrometry (MS), as protected peptide intermediates are often marked by poor solubility, structural lability, and low ionization potential. Matrix-assisted laser desorption/ionization (MALDI) MS is uniquely suited to such analytes; however, generalized protocols for MALDI analysis of protected peptides have yet to be demonstrated. Herein, we report an operationally simple sample preparation method for MALDI analysis of protected peptides, which greatly facilitates the collection and interpretation of MS data. In this method, the difficulty in MS analysis of protected peptides has been greatly diminished by use of dithranol as a matrix and CsCl as an additive, giving rise to intentionally-formed Cs(+) adducts. With greatly reduced fragmentation, better crystalline morphology, and easier data interpretation, we anticipate that these findings will find utility in peptide process development and manufacturing settings for reaction monitoring, troubleshooting, and quality control.
authors.affiliation: Roche Colorado Corporation, Boulder Technology Center, Boulder, CO 80301, USA.
authors.forename: Audrey M
authors.initials: AM
authors.lastname: Schaiberger
authors.forename: Jason A
authors.initials: JA
authors.lastname: Moss
mesh_terms: D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000032:analysis / Q000138:chemical synthesis; D023581:HIV Fusion Inhibitors / Q000032:analysis / Q000138:chemical synthesis; D010446:Peptide Fragments / Q000032:analysis* / Q000138:chemical synthesis; D013048:Specimen Handling / Q000379:methods*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*
chemical_list: D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide